soul trial oral semaglutide cardiovascular outcomes 2024 nejm results 🧿 is the first oral GLP-1 RA proven to reduce MACE in high-risk T2DM patients, extending protection beyond injectable formulations. Trial: Oral Semaglutide & Cardiovascular in T2DM soul trial oral semaglutide cardiovascular

We strongly encourage you to speak to a healthcare provider to assess if this type of treatment is appropriate for your unique needs

Co-authors: Phil Baker, PharmD Send download link to: If one pharmacist calls another and asks if they have any of this years most popular drug, they dont even have to say a name

Sales of gum rose 5% in 2023, but were still 10% under 2018 numbers

If you're in Burbank and exploring semaglutide weight loss solutions, Wegovy is the drug crafted specifically for this purpose

This growing issue is shown by data presented at the American Academy of Orthopedic Surgeons, and was recently written about in The Washington Post

Dietary Changes to Reduce Tirzepatide-Related Diarrhea Switching to a low-fiber diet during the first 24 weeks of tirzepatide therapy can significantly reduce diarrhea frequency